AstraZeneca Asthma Trial Shows Slowed Use of Steroids

AstraZeneca has released phase 3 clinical trial information linking their newest asthma medication with reduced oral steroid use in patients with severe asthmatic symptoms. The drug, Benralizumab, shows a limited need for steroids, which according to an AstraZeneca...